Pascal Touchon, President and CEO at Atara Biotherapeutics, Inc. (ATRA), sold 9,614 shares at $12.09 ($116K) on 2020-08-18, disclosed to the SEC on 2020-08-20.
Open-market sale of $116k ATRA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.09 | 4,807 | $58K | 50.0% |
| 2 | $12.09 | 4,807 | $58K | 50.0% |
| Total | $12.09 avg | 9,614 | $116K | 100% |
| Filing → |
| ATRA | SELL | 2024-03-06 | $18K | — | Filing → |
| ATRA | SELL | 2023-11-20 | $8K | — | Filing → |
| ATRA | SELL | 2023-08-18 | $51K | — | Filing → |